US Senate committee investigates pricing of Novo's Ozempic and Wegovy

A U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's (NOVOb.CO), opens new tab diabetes and weight loss drugs Ozempic and Wegovy in the United States.